LCM
GILD icon

LCM Capital Management’s Gilead Sciences GILD Stock Holding History

LCM Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.23M Buy
8,828
+58
+0.7% +$8.12K 0.62% 27
2025
Q4 		$1.08M Sell
8,770
-910
-9% -$111K 0.52% 33
2025
Q3 		$1.07M Sell
9,680
-27
-0.3% -$3.07K 0.52% 33
2025
Q2 		$1.08M Buy
9,707
+56
+0.6% +$5.96K 0.56% 33
2025
Q1 		$1.08M Buy
9,651
+224
+2% +$23.1K 0.64% 30
2024
Q4 		$871K Buy
9,427
+31
+0.3% +$2.79K 0.49% 39
2024
Q3 		$788K Buy
9,396
+206
+2% +$15.7K 0.45% 40
2024
Q2 		$631K Buy
9,190
+237
+3% +$15.8K 0.39% 41
2024
Q1 		$656K Buy
8,953
+19
+0.2% +$1.46K 0.42% 42
2023
Q4 		$724K Buy
8,934
+23
+0.3% +$1.79K 0.52% 34
2023
Q3 		$668K Buy
8,911
+412
+5% +$31.7K 0.54% 33
2023
Q2 		$655K Buy
8,499
+113
+1% +$9.01K 0.53% 35
2023
Q1 		$696K Buy
8,386
+451
+6% +$37.4K 0.61% 33
2022
Q4 		$681K Buy
7,935
+5
+0.1% +$396 0.66% 30
2022
Q3 		$489K Sell
7,930
-32
-0.4% -$2.02K 0.52% 35
2022
Q2 		$492K Sell
7,962
-2
-0% -$124 0.48% 40
2022
Q1 		$473K Buy
7,964
+330
+4% +$21.1K 0.38% 47
2021
Q4 		$554K Buy
7,634
+317
+4% +$21.8K 0.43% 44
2021
Q3 		$511K Buy
7,317
+18
+0.2% +$1.26K 0.43% 46
2021
Q2 		$503K Sell
7,299
-134
-2% -$8.95K 0.42% 45
2021
Q1 		$480K Sell
7,433
-272
-4% -$17.5K 0.43% 46
2020
Q4 		$449K Buy
+7,705
New +$465K 0.43% 43

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

LCM Capital Management's GILD Position: Q1 2026 in Review

LCM Capital Management increased its Gilead Sciences (GILD) stake by 0.66% in Q1 2026, buying an estimated $8.12K and bringing the position to 8,828 shares worth $1.23M. The position accounts for 0.62% of the portfolio, ranked #27.

LCM Capital Management first reported a position in GILD in Q4 2020 and has held it in 22 quarters since. 2,310 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • LCM Capital Management held 8,828 shares of Gilead Sciences worth $1.23M as of Q1 2026.
  • LCM Capital Management bought 58 Gilead Sciences shares in Q1 2026, an estimated $8.12K.
  • Gilead Sciences made up 0.62% of LCM Capital Management's portfolio in Q1 2026, its #27 holding.
  • LCM Capital Management first reported a position in Gilead Sciences in Q4 2020 and has held it in 22 quarters since.
  • 2,310 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on LCM Capital Management's 13F filing for Q1 2026, filed 21 Apr 2026.